Pancreatic Cancer Research

ResearcherGenomics Research Center, Academia SinicaActive in the last 2 years

Sui-Chih Tien

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5042904159. Sources: OpenAlex.

Their work

Papers
7 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: 3 papers

Papers 7

  1. Innovative cyclic peptide disrupts IL-17RB-MLK4 interaction for targeted pancreatic cancer therapy. First author DOI 10.1016/j.biopha.2025.117892↗
  2. Correction: SEMA7A-mediated juxtacrine stimulation of IGFBP-3 upregulates IL-17RB at pancreatic cancer invasive front. First author DOI 10.1038/s41417-024-00857-6↗
  3. RRM1 O-GlcNAcylation inhibition suppresses pancreatic cancer via TK1-mediated replication stress. Co-author DOI 10.1038/s41417-025-00895-8↗
  4. Exosomal miRNA 16-5p/29a-3p from pancreatic cancer induce adipose atrophy by inhibiting adipogenesis and promoting lipolysis. Co-author DOI 10.1016/j.isci.2024.110346↗
  5. SEMA7A-mediated juxtacrine stimulation of IGFBP-3 upregulates IL-17RB at pancreatic cancer invasive front. First author DOI 10.1038/s41417-024-00849-6↗
  6. Pancreatic cancer-derived small extracellular vesical ezrin activates fibroblasts to exacerbate cancer metastasis through STAT3 and YAP-1 signaling pathways. Co-author DOI 10.1002/1878-0261.13442↗
  7. Pancreatic cancer-derived small extracellular vesical Ezrin regulates macrophage polarization and promotes metastasis. Co-author PMID 32064151↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chun‐Mei Hu · 7 shared papers, 2020–2025 · strength 1.65
  2. Hsuan‐Yu Peng · 5 shared papers, 2020–2025 · strength 0.99
  3. Yu‐Ting Chang · 5 shared papers, 2020–2025 · strength 0.99
  4. Ming‐Chu Chang · 4 shared papers, 2023–2025 · strength 0.86
  5. Y.M. Chen · 2 shared papers, 2024–2025 · strength 0.42
  6. Yu‐Wen Tien · 2 shared papers, 2024–2025 · strength 0.42
  7. Yung‐Ming Jeng · 2 shared papers, 2020–2023 · strength 0.34
  8. Wei‐Chieh Cheng · 1 shared paper, 2025 · strength 0.23
  9. Wen‐Hwa Lee · 1 shared paper, 2024 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.